Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Revenue

Xbrane Biopharma AB had revenue of 46.75M SEK in the quarter ending June 30, 2026, with 17.14% growth. This brings the company's revenue in the last twelve months to 83.30M, down -61.28% year-over-year. In the year 2025, Xbrane Biopharma AB had annual revenue of 152.35M with 2.87% growth.

• Revenue (ttm): 83.30M
• Revenue Growth: -61.28%
• P/S Ratio: 2.51
• Revenue / Employee: 2.87M
• Employees: 29
• Market Cap: 209.14M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	152.35M	4.26M	2.87%
Dec 31, 2024	148.10M	-90.63M	-37.96%
Dec 31, 2023	238.73M	181.11M	314.33%
Dec 31, 2022	57.62M	46.91M	438.03%
Dec 31, 2021	10.71M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	20.49M	-286.00K	-1.38%
Dec 31, 2017	20.77M	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	392.86K	203.23K	107.17%
Dec 31, 2014	189.63K	104.00	0.05%
Dec 31, 2013	189.52K	-	-

Data Source: Fiscal.ai Last updated: Jul 17, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error